Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Test    source : Www.nantkwest.com    save search
ImmunityBio Expands Trials of T-Cell-Based COVID-19 Vaccine Candidate as a ‘Universal Boost’ in Vaccinated Subjects and Receives Approval to Test Intranasal Spray in South Africa
Published: 2021-05-25 (Crawled : 13:15) - nantkwest.com
IBRX | $5.645 14.27% 27M twitter stocktwits trandingview |
Manufacturing
 | | O: 2.23% H: 2.37% C: -1.93%
covid nasal spray test vaccine trial approval t-cell africa
Gainers vs Losers
85% 15%

Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M twitter stocktwits trandingview |

AGBA | $2.99 139.2% 64M twitter stocktwits trandingview |
Finance
CZOO | $8.67 73.75% 23M twitter stocktwits trandingview |

EDBL | News | $6.47 72.07% 1.9M twitter stocktwits trandingview |

MTC | $2.21 41.67% 5.6M twitter stocktwits trandingview |
Technology Services
OPRT | News | $3.12 38.67% 11M twitter stocktwits trandingview |
Finance
PALI | $6.59 33.67% 23M twitter stocktwits trandingview |
Manufacturing
VNRX | $0.7989 33.15% 3.2M twitter stocktwits trandingview |
Health Technology
BTCM | $3.51 30.0% 730K twitter stocktwits trandingview |
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.